Total planned funding: $1,391,800,367
Clear active filters
Chemonics International
Private Contractor
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
Allocations
Countries/Regions
Nigeria | $240,363,176 |
Zambia | $217,103,233 |
Tanzania | $213,093,278 |
Mozambique | $138,857,879 |
Uganda | $118,064,193 |
Kenya | $96,894,539 |
Zimbabwe | $74,357,669 |
Haiti | $47,038,734 |
Democratic Republic of the Congo | $45,479,301 |
Rwanda | $37,322,056 |
Côte d'Ivoire | $31,120,224 |
Ethiopia | $29,081,948 |
Vietnam | $16,173,515 |
Eswatini | $15,110,343 |
Ukraine | $11,470,699 |
Burundi | $8,336,615 |
Malawi | $7,140,511 |
Lesotho | $6,054,620 |
West Africa Region | $5,678,527 |
Angola | $5,531,238 |
Cameroon | $4,797,605 |
Namibia | $4,625,294 |
South Sudan | $4,145,007 |
South Africa | $3,957,311 |
Western Hemisphere Region | $2,048,556 |
Asia Regional Program | $1,814,606 |
Ghana | $1,750,000 |
Caribbean Region | $1,233,936 |
Indonesia | $900,001 |
Botswana | $750,003 |
Central America Region | $565,750 |
Burma | $550,000 |
Central Asia Region | $250,000 |
Cambodia | $140,000 |
Organizational Types
Private Contractor | $1,391,800,367 |
Program Areas
Treatment | $1,132,341,653 |
Care | $92,639,059 |
Prevention | $79,473,965 |
Governance and Systems | $62,517,766 |
Testing | $24,827,924 |
Budget Codes
HTXD: Treatment: ARV Drugs | $741,707,821 |
HTXS: Treatment: Adult Treatment | $319,280,729 |
PDTX: Treatment: Pediatric Treatment | $71,353,103 |
OHSS: Health Systems Strengthening | $53,407,241 |
HBHC: Care: Adult Care and Support | $41,505,330 |
HVOP: Sexual Prevention: Other Sexual Prevention | $35,679,372 |
HVTB: Care: TB/HIV | $34,736,526 |
HVCT: Testing: HIV Testing and Counseling | $24,827,924 |
CIRC: Biomedical Prevention: Voluntary Medical Male Circumcision | $23,937,817 |
MTCT: Biomedical Prevention: Prevention of Mother to Child Transmission | $17,729,187 |
PDCS: Care: Pediatric Care and Support | $10,597,203 |
HLAB: Laboratory Infrastructure | $7,902,191 |
HKID: Care: Orphans and Vulnerable Children | $5,800,000 |
HVSI: Strategic Information | $1,208,334 |
IDUP: Prevention: Injecting and Non-Injecting Drug Use | $869,530 |
HVAB: Sexual Prevention: Abstinence/Be Faithful | $618,405 |
HMBL: Biomedical Prevention: Blood Safety | $474,023 |
HMIN: Biomedical Prevention: Injection Safety | $165,631 |
Top Partner Programs
Chemonics International:
$1,391,800,367
View countries